Medpace Holdings, Inc.· MEDP
🇺🇸 US · LargeSP400NASDAQ
- Price
- $575.08
- Day
- +0.31%
- Mkt Cap
- $16.05B
- 52W Range
- $373.00 – $677.90
- Volume
- 227.9K
- Beta
- 1.15
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read full article
First Trust Advisors LP reduced its position in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) by 4.4% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 64,677 shares of the company's stock after selling 3,008 shares during the quarter. First Trust Advisors
Read full article
American Capital Management Inc. lessened its holdings in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) by 2.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 217,947 shares of the company's stock after selling 6,427 shares during the period. Medpace accounts
Read full article
Medpace (MEDP) could produce exceptional returns because of its solid growth attributes.
Read full article
Dimensional Fund Advisors LP cut its position in Medpace Holdings, Inc. (NASDAQ: MEDP) by 3.0% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 348,485 shares of the company's stock after selling 10,865 shares during the period. Dimensional Fund Advisors LP owned about
Read full article
Medpace Holdings demonstrates strong Q2 2026 net new business awards, with a 1.13x net book-to-bill and $3.0B backlog. Oncology bookings are robust, while cardiometabolic awards have declined; management expects mix normalization over the next year. Guidance is lifted on improved RFP trends, biotech funding breadth, and moderated cancellations, supporting growth momentum into 2027.
Read full article
Arrowstreet Capital Limited Partnership grew its holdings in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) by 5.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 395,769 shares of the company's stock after buying an additional 20,736 shares during the quarter. Arrowstreet
Read full article
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read full article
Medpace Holdings Inc. (NASDAQ:MEDP) stock is trading higher on Thursday on better-than-expected second-quarter financial results and raised its fiscal 2026 guidance.
Read full article
Medpace Holdings, Inc. (MEDP) Q2 2026 Earnings Call Transcript
Read full article
Medpace NASDAQ: MEDP reported double-digit growth in second-quarter revenue and earnings, while management described the business environment as strong and said lower cancellations helped drive record net bookings.
Read full article
Medpace Holdings remains a "Buy" as Q2 2026 showed broad metric improvement and an inflection point in growth trajectory. The company's net book-to-Bill ratio rebounded to 1.13x, and backlog conversion rate rose to 24.1%, signaling strong future revenue visibility. Revenue grew 17.2% YoY to $707.3M, with EPS of $4.25 beating expectations; full-year 2026 guidance was raised to $2.805B–$2.885B.
Read full article